Palisade Bio (PALI) Net Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | 70.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.78% |
| Dec 31, 2025 | 7,097.47% |
| Sep 30, 2025 | 94.27% |
| Jun 30, 2025 | -2,454.55% |
| Mar 31, 2025 | -124.13% |
| Dec 31, 2024 | 161.84% |
| Sep 30, 2024 | -203.67% |
| Jun 30, 2024 | -97.52% |
| Mar 31, 2024 | -226.48% |
| Dec 31, 2023 | -79.78% |
| Sep 30, 2023 | -112.12% |
| Jun 30, 2023 | 286.90% |
| Mar 31, 2023 | 123.73% |
| Dec 31, 2022 | 55.61% |
| Sep 30, 2022 | 520.61% |
| Jun 30, 2022 | -114.17% |
| Mar 31, 2022 | -3,829.59% |
| Dec 31, 2021 | -9,397.37% |
| Sep 30, 2021 | 288.93% |
| Jun 30, 2021 | 268.06% |
| Mar 31, 2021 | -101.99% |
| Dec 31, 2020 | 98.26% |
| Sep 30, 2020 | -115.28% |
| Jun 30, 2020 | -305.69% |
| Mar 31, 2020 | 375.72% |
| Dec 31, 2019 | -4,245.16% |
| Sep 30, 2019 | 471.51% |
| Jun 30, 2019 | 34.48% |
| Mar 31, 2019 | -158.48% |
| Dec 31, 2018 | 102.21% |
| Sep 30, 2018 | -151.58% |
| Jun 30, 2018 | 48.90% |
| Mar 31, 2018 | 186.76% |
| Dec 31, 2017 | -125.10% |
| Sep 30, 2017 | 148.08% |
| Jun 30, 2017 | -246.68% |
| Mar 31, 2017 | -220.98% |
| Dec 31, 2016 | 213.18% |
| Sep 30, 2016 | -221.64% |
| Jun 30, 2016 | 170.94% |
| Mar 31, 2016 | 170.39% |
| Dec 31, 2015 | -1,565.88% |
| Sep 30, 2015 | 236.39% |
| Jun 30, 2015 | -58.95% |
| Mar 31, 2015 | -28.27% |
| Dec 31, 2014 | 29.39% |
| Sep 30, 2014 | -162.85% |
| Jun 30, 2014 | -108.31% |
| Mar 31, 2014 | -71.28% |
| Dec 31, 2013 | 118.25% |
| Sep 30, 2013 | -28.68% |
| Jun 30, 2013 | 42.67% |
| Mar 31, 2013 | 86.79% |
| Dec 31, 2012 | -31.80% |
| Sep 30, 2012 | 476.80% |
| Jun 30, 2012 | -8.32% |
| Mar 31, 2012 | 490.61% |
| Dec 31, 2011 | 20.80% |
| Sep 30, 2011 | 20.13% |